Clinical trial
Multicenter, Prospective, Non-interventional, Observational Study to Confirm the Long-term Efficacy and Safety of Rosuampin Tab. in Patients With Hypertension and Hypercholesterolemia
NCT06293261 is registered in ClinicalTrials.gov with Yuhan Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multicenter, Prospective, Non-interventional, Observational Study to Confirm the Long-term Efficacy and Safety of Rosuampin Tab. in Patients With Hypertension and Hypercholesterolemia
- Lead sponsor
- Yuhan Corporation
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 27, 2020
- Completion date
- March 31, 2024
- Enrollment
- 5,047 (actual)
- Sites
- 39
Conditions
As the registry lists them; a condition with its own page is linked.